Our study and many others have been retrospective; a prospective design would allow standardized CRP monitoring and timely correlation with detected infections, helping to establish evidence-based cutoff values (for example, confirming whether CRP > 100 mg/L on postoperative day 4–5 truly predicts thoracic complications with high sensitivity and acceptable false-positive rates). This evidence concerns the gene CRP and infection.